Deacu L G, Niculescu D A, Terzea D, Cristea C, Ioachim D, Poiana C
Pituitary and Neuroendocrine Disorders, "C.I. Parhon" National Institute of Endocrinology, Romania.
"Carol Davila" University of Medicine and Pharmacy, Endocrinology Bucharest, Romania.
Acta Endocrinol (Buchar). 2022 Jul-Sep;18(3):343-349. doi: 10.4183/aeb.2022.343.
Thyroid fine-needle aspiration (FNA) cytology is the best tool for preoperative diagnosis of thyroid carcinoma; however, its learning curve is poorly described. Our aim was to assess the learning curve of a new thyroid FNA center involving unexperienced operator and pathologist.
We retrieved from our tertiary endocrinology center database all thyroid FNA procedures done by a single operator (endocrinologist with no experience in FNA) between 2018 and 2021. Cytology was assessed by two pathologists with limited or no experience in thyroid cytology. We also got the corresponding sex, age, nodule diameter, EU-TIRADS score, Bethesda category and final pathology report.
There were 1872 FNA in 1618 patients. Proportion of Bethesda 1 nodules decreased significantly (p for trend=0.003) from 17% in the first 100 FNA procedures to 4% in the 401-500 group of procedures, and remained constant between 9% and 4% (p for trend=NS) for the rest of the study. Proportion of Bethesda 2 rose steady from 26% in the first 100 nodules to 80.1% in the last 241 nodules (p for trend<0.001). Indeterminate lesions (Bethesda 3 and 4) decreased significantly (p for trend=0.001) from 16% and 35% in the first 100 nodules to 2.5% and 5.8% in the last 241 lesions. Proportions of Bethesda 5+6 categories varied non-significantly over time. There were no time trends in the malignancy rate of surgically removed nodules.
At least 300 procedures are needed to reach the standard performance. A steadily state for the whole center is obtained after about 500 procedures.
甲状腺细针穿刺(FNA)细胞学检查是术前诊断甲状腺癌的最佳工具;然而,其学习曲线描述甚少。我们的目的是评估一个新的甲状腺FNA中心的学习曲线,该中心涉及缺乏经验的操作人员和病理学家。
我们从三级内分泌中心数据库中检索了2018年至2021年间由一名操作人员(无FNA经验的内分泌科医生)完成的所有甲状腺FNA操作。细胞学检查由两名甲状腺细胞学经验有限或无经验的病理学家进行评估。我们还获取了相应的性别、年龄、结节直径、EU-TIRADS评分、贝塞斯达分类和最终病理报告。
1618例患者共进行了1872次FNA。贝塞斯达1类结节的比例从最初100次FNA操作中的17%显著下降(趋势p=0.003)至第401-500组操作中的4%,在研究的其余阶段保持在9%至4%之间(趋势p=无显著性差异)。贝塞斯达2类结节的比例从最初100个结节中的26%稳步上升至最后241个结节中的80.1%(趋势p<0.001)。不确定病变(贝塞斯达3类和4类)从最初100个结节中的16%和35%显著下降(趋势p=0.001)至最后241个病变中的2.5%和5.8%。贝塞斯达5+6类的比例随时间变化无显著性差异。手术切除结节的恶性率无时间趋势。
至少需要300次操作才能达到标准性能。整个中心在大约500次操作后达到稳定状态。